Changes in serum creatinine in patients with active rheumatoid arthritis treated with tofacitinib: results from clinical trials
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6354
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Changes in serum creatinine in patients with active rheumatoid arthritis treated with tofacitinib: results from clinical trials ; volume:16 ; number:4 ; day:25 ; month:7 ; year:2014 ; pages:1-12 ; date:8.2014
Arthritis Research & Therapy ; 16, Heft 4 (25.7.2014), 1-12, 8.2014
- Urheber
-
Isaacs, John D.
- Beteiligte Personen und Organisationen
-
Zuckerman, Andrea
Krishnaswami, Sriram
Nduaka, Chudy
Lan, Shuping
Hutmacher, Matthew M.
Boy, Mary G.
Kowalski, Ken
Menon, Sujatha
Riese, Richard
SpringerLink (Online service)
- DOI
-
10.1186/ar4673
- URN
-
urn:nbn:de:1111-201605191097
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Isaacs, John D.
- Zuckerman, Andrea
- Krishnaswami, Sriram
- Nduaka, Chudy
- Lan, Shuping
- Hutmacher, Matthew M.
- Boy, Mary G.
- Kowalski, Ken
- Menon, Sujatha
- Riese, Richard
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib
Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trials
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trials
Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis
Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of phase II/III trials
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group
Machine learning prediction and explanatory models of serious infections in patients with rheumatoid arthritis treated with tofacitinib
Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis
Tofacitinib Efficacy in Patients with Rheumatoid Arthritis and Probable Depression/Anxiety: Post Hoc Analysis of Phase 3 and 3b/4 Randomized Controlled Trials
Atypical presentation of Pneumocystis jirovecii pneumonia in a patient with rheumatoid arthritis treated with tofacitinib: a case presentation
Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib
Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trials
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trials
Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis
Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of phase II/III trials
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group
Machine learning prediction and explanatory models of serious infections in patients with rheumatoid arthritis treated with tofacitinib
Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis
Tofacitinib Efficacy in Patients with Rheumatoid Arthritis and Probable Depression/Anxiety: Post Hoc Analysis of Phase 3 and 3b/4 Randomized Controlled Trials
Atypical presentation of Pneumocystis jirovecii pneumonia in a patient with rheumatoid arthritis treated with tofacitinib: a case presentation
Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib
Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trials
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trials
Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis
Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of phase II/III trials
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group
Machine learning prediction and explanatory models of serious infections in patients with rheumatoid arthritis treated with tofacitinib
Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis
Tofacitinib Efficacy in Patients with Rheumatoid Arthritis and Probable Depression/Anxiety: Post Hoc Analysis of Phase 3 and 3b/4 Randomized Controlled Trials